KRT is trading at a deep discount to its own momentum: the stock has jumped 22% in a week and 46% in a month, while the only analyst with a live target is still pointing to $34 — well below Tuesday's close of $50.06.
The most striking feature of KRT's current setup is the gap between what the stock has done and what the earnings reaction started. The company reported on August 6 and the shares jumped 11.2% on the day. That print — ahead of what was already an elevated bar — kicked off a run that has barely paused. The EPS surprise factor score ranks in the 95th percentile across the entire universe, near the top of all US-listed names on that dimension. Whatever the company delivered, it was meaningfully better than expected, and the market is still repricing.
Positioning in the lending market offers no resistance to the rally. Borrow availability is among the loosest it has been all year — roughly 4,270% of short interest is available to lend, up more than 50% on the week, meaning the pool of shares available to borrow is enormous relative to what's actually been shorted. Cost to borrow is a negligible 0.50%, barely above the prime rate. Short interest itself has fallen 9% over the past week to just 1.3% of free float — fewer than 260,000 shares net short. There is no short-side overhang to unwind, no squeeze story, no friction in the borrow market. The shorts have been exiting, not building.
The Street, however, has been slow to follow. The most recent analyst move was B of A Securities raising its target from $23 to $34 in mid-July — still 32% below where the stock now trades. That target was set before the August earnings beat. The current mean price target of $41.50 is similarly stale relative to Tuesday's close, implying the consensus has not yet incorporated post-earnings levels. William Blair upgraded the stock to Outperform back in June without setting a target, which now looks prescient. The ORTEX short score has been drifting lower — from 35.1 a week ago to 33.3 today — reflecting the sustained easing in short-side pressure as the stock has climbed.
The ownership picture adds useful context. Alan Yu, Chairman and CEO, holds 30.6% of shares; co-founder Marvin Cheng holds another 26.4%. Together they control nearly 57% of the company. Combined with modest institutional float, this creates a structurally thin free float — which helps explain how a post-earnings re-rating can travel this far, this fast. Vanguard added an entirely new position as recently as June 30, and BlackRock incrementally added in July, but these are small adjustments relative to the founder-dominated cap table. The stock's peer group — DSGR, BCC, BNZL — has been largely flat to slightly up this week, making KRT's 22% move look entirely company-specific rather than sector-driven.
With no analyst targets currently above the stock price and the next earnings not until early November, the week ahead will test whether buyers at $50 are content to hold into a quiet period — or whether the gap between price and consensus invites fresh target upgrades that could extend the move.
See the live data behind this article on ORTEX.
Open KRT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
